Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer
Schmid-Bindert, Gerald, Gebbia, Vittorio, Mayer, Frank, Arriola, Edurne, Márquez-Medina, Diego, Syrigos, Kostas, Biesma, Bonne, Leschinger, Monika Iris, Frimodt-Moller, Bente, Ripoche, Veronique, Myrand, Scott P, Nguyen, Tuan S, Hozak, Rebecca R, Zimmermann, Annamaria, Visseren-Grul, Carla, Schuette, Wolfgang
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2013)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2013)
Get full text
Journal Article
Phase II study of pemetrexed (Pem) and cisplatin (Cis) plus cetuximab (Cet) followed by Pem and Cet maintenance therapy in patients (Pts) with advanced nonsquamous non-small cell lung cancer (NSCLC)
Schmid-Bindert, Gerald, Gebbia, Vittorio, Mayer, Frank, Arriola, Edurne, Marquez-Medina, Diego, Syrigos, Konstantinos N., Biesma, Bonne, Leschinger, Monika Iris, Visseren Grul, Carla M., Frimodt-Moller, Bente, Ripoche, Veronique, Myrand, Scott, Nguyen, Tuan, Zimmermann, Annamaria, Schuette, Wolfgang
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article